Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001032290 | SCV001195597 | pathogenic | Progressive myoclonic epilepsy type 3 | 2019-10-29 | criteria provided, single submitter | clinical testing | A gross deletion of the genomic region encompassing the full coding sequence of the KCTD7 gene has been identified. The boundaries of this event are unknown as the deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. This variant has not been reported in the literature in individuals with KCTD7-related conditions. Loss-of-function variants in KCTD7 are known to be pathogenic (PMID: 22693283). For these reasons, this variant has been classified as Pathogenic. |